These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1734 related articles for article (PubMed ID: 35786336)

  • 1. Machine Learning and Artificial Intelligence: A Paradigm Shift in Big Data-Driven Drug Design and Discovery.
    Pasrija P; Jha P; Upadhyaya P; Khan MS; Chopra M
    Curr Top Med Chem; 2022; 22(20):1692-1727. PubMed ID: 35786336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial intelligence to deep learning: machine intelligence approach for drug discovery.
    Gupta R; Srivastava D; Sahu M; Tiwari S; Ambasta RK; Kumar P
    Mol Divers; 2021 Aug; 25(3):1315-1360. PubMed ID: 33844136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent trends in artificial intelligence-driven identification and development of anti-neurodegenerative therapeutic agents.
    Kashyap K; Siddiqi MI
    Mol Divers; 2021 Aug; 25(3):1517-1539. PubMed ID: 34282519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolving scenario of big data and Artificial Intelligence (AI) in drug discovery.
    Tripathi MK; Nath A; Singh TP; Ethayathulla AS; Kaur P
    Mol Divers; 2021 Aug; 25(3):1439-1460. PubMed ID: 34159484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of artificial intelligence to drug design and discovery in the big data era: a comprehensive review.
    Tripathi N; Goshisht MK; Sahu SK; Arora C
    Mol Divers; 2021 Aug; 25(3):1643-1664. PubMed ID: 34110579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From machine learning to deep learning: progress in machine intelligence for rational drug discovery.
    Zhang L; Tan J; Han D; Zhu H
    Drug Discov Today; 2017 Nov; 22(11):1680-1685. PubMed ID: 28881183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Big Data and Artificial Intelligence Modeling for Drug Discovery.
    Zhu H
    Annu Rev Pharmacol Toxicol; 2020 Jan; 60():573-589. PubMed ID: 31518513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of Artificial Intelligence and Machine Learning in Drug Discovery.
    Gupta RR
    Methods Mol Biol; 2022; 2390():113-124. PubMed ID: 34731466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial Intelligence and Machine Learning Technology Driven Modern Drug Discovery and Development.
    Sarkar C; Das B; Rawat VS; Wahlang JB; Nongpiur A; Tiewsoh I; Lyngdoh NM; Das D; Bidarolli M; Sony HT
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New avenues in artificial-intelligence-assisted drug discovery.
    Cerchia C; Lavecchia A
    Drug Discov Today; 2023 Apr; 28(4):103516. PubMed ID: 36736583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Big data and artificial intelligence (AI) methodologies for computer-aided drug design (CADD).
    Lee JW; Maria-Solano MA; Vu TNL; Yoon S; Choi S
    Biochem Soc Trans; 2022 Feb; 50(1):241-252. PubMed ID: 35076690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial Intelligence, Big Data and Machine Learning Approaches in Precision Medicine & Drug Discovery.
    Nayarisseri A; Khandelwal R; Tanwar P; Madhavi M; Sharma D; Thakur G; Speck-Planche A; Singh SK
    Curr Drug Targets; 2021; 22(6):631-655. PubMed ID: 33397265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artificial intelligence in drug discovery: recent advances and future perspectives.
    Jiménez-Luna J; Grisoni F; Weskamp N; Schneider G
    Expert Opin Drug Discov; 2021 Sep; 16(9):949-959. PubMed ID: 33779453
    [No Abstract]   [Full Text] [Related]  

  • 14. Deep Learning for Drug Design: an Artificial Intelligence Paradigm for Drug Discovery in the Big Data Era.
    Jing Y; Bian Y; Hu Z; Wang L; Xie XQ
    AAPS J; 2018 Mar; 20(3):58. PubMed ID: 29603063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current strategies to address data scarcity in artificial intelligence-based drug discovery: A comprehensive review.
    Gangwal A; Ansari A; Ahmad I; Azad AK; Wan Sulaiman WMA
    Comput Biol Med; 2024 Sep; 179():108734. PubMed ID: 38964243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the artificial intelligence and machine learning models in the context of drug design difficulties and future potential for the pharmaceutical sectors.
    Shiammala PN; Duraimutharasan NKB; Vaseeharan B; Alothaim AS; Al-Malki ES; Snekaa B; Safi SZ; Singh SK; Velmurugan D; Selvaraj C
    Methods; 2023 Nov; 219():82-94. PubMed ID: 37778659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CADD, AI and ML in drug discovery: A comprehensive review.
    Vemula D; Jayasurya P; Sushmitha V; Kumar YN; Bhandari V
    Eur J Pharm Sci; 2023 Feb; 181():106324. PubMed ID: 36347444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery.
    Yang X; Wang Y; Byrne R; Schneider G; Yang S
    Chem Rev; 2019 Sep; 119(18):10520-10594. PubMed ID: 31294972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificial intelligence and machine-learning approaches in structure and ligand-based discovery of drugs affecting central nervous system.
    Gautam V; Gaurav A; Masand N; Lee VS; Patil VM
    Mol Divers; 2023 Apr; 27(2):959-985. PubMed ID: 35819579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial Intelligence (AI) in Drugs and Pharmaceuticals.
    Sahu A; Mishra J; Kushwaha N
    Comb Chem High Throughput Screen; 2022; 25(11):1818-1837. PubMed ID: 34875986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 87.